The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates

The justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence att...

Full description

Bibliographic Details
Main Authors: Beata Sadowska, Urszula Wójcik, Justyna Krzyżanowska-Kowalczyk, Mariusz Kowalczyk, Anna Stochmal, Joanna Rywaniak, Julia Burzyńska, Barbara Różalska
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/6/1151
id doaj-a96588feb58b429d82d034af4477f173
record_format Article
spelling doaj-a96588feb58b429d82d034af4477f1732020-11-25T01:05:22ZengMDPI AGMolecules1420-30492019-03-01246115110.3390/molecules24061151molecules24061151The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical IsolatesBeata Sadowska0Urszula Wójcik1Justyna Krzyżanowska-Kowalczyk2Mariusz Kowalczyk3Anna Stochmal4Joanna Rywaniak5Julia Burzyńska6Barbara Różalska7Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandThe justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence attributes of CF-associated <i>Staphylococcus aureus</i> (<i>S. aureus</i>) clinical strains has been assessed, including pathogen adhesion, biofilm formation on native and protein-conditioned surfaces (mucin, elastin), mature biofilm eradication, staphylococcal protein A expression, &#945;-toxin release, and <i>S. a.</i> adhesion to A549 cells. Cytotoxicity of the extract to lung epithelial cells was also investigated. It was found that POE has bacteriostatic effects at MIC 1&#8211;2 mg/mL, recognized as of limited efficacy, but at MIC/subMICs it targeted virulence not viability. It usually decreased <i>S. aureus</i> adhesion and less frequently inhibited biofilm formation on native and protein-conditioned surfaces. Observed effect seems to be related to significant reduction by POE of sortase A activity. However, in some cases POE favored the creation of biofilm by staphylococci and <i>S. aureus</i> adhesion to the lung epithelium was not limited. On the other side POE caused significant decrease of <i>S. a.</i> &#945;-toxin synthesis and slightly weakened the expression of SpA. When used at supraMICs POE eradicated mature biofilm, but in some cases with unsatisfying outcomes. Promisingly, POE has been recognized as a safe product, with no cytotoxicity up to 4 mg/mL. These results reflect the positive, negative or neutral anti-staphylococcal properties of POE. It seems that POE may be beneficial as a prophylactic, but not as a therapeutic or supportive agent in the area of CF&#8212;integrative medicine. However, introduction the official recommendations needs further in vivo studies.https://www.mdpi.com/1420-3049/24/6/1151lungwort fractionated phenolic extractcystic fibrosis<i>Staphylococcus aureus</i>adhesionbiofilmcytotoxicity
collection DOAJ
language English
format Article
sources DOAJ
author Beata Sadowska
Urszula Wójcik
Justyna Krzyżanowska-Kowalczyk
Mariusz Kowalczyk
Anna Stochmal
Joanna Rywaniak
Julia Burzyńska
Barbara Różalska
spellingShingle Beata Sadowska
Urszula Wójcik
Justyna Krzyżanowska-Kowalczyk
Mariusz Kowalczyk
Anna Stochmal
Joanna Rywaniak
Julia Burzyńska
Barbara Różalska
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
Molecules
lungwort fractionated phenolic extract
cystic fibrosis
<i>Staphylococcus aureus</i>
adhesion
biofilm
cytotoxicity
author_facet Beata Sadowska
Urszula Wójcik
Justyna Krzyżanowska-Kowalczyk
Mariusz Kowalczyk
Anna Stochmal
Joanna Rywaniak
Julia Burzyńska
Barbara Różalska
author_sort Beata Sadowska
title The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
title_short The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
title_full The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
title_fullStr The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
title_full_unstemmed The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
title_sort <i>pros</i> and <i>cons</i> of cystic fibrosis (cf) patient use of herbal supplements containing <i>pulmonaria officinalis</i> l. extract: the evidence from an in vitro study on <i>staphylococcus aureus</i> cf clinical isolates
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2019-03-01
description The justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence attributes of CF-associated <i>Staphylococcus aureus</i> (<i>S. aureus</i>) clinical strains has been assessed, including pathogen adhesion, biofilm formation on native and protein-conditioned surfaces (mucin, elastin), mature biofilm eradication, staphylococcal protein A expression, &#945;-toxin release, and <i>S. a.</i> adhesion to A549 cells. Cytotoxicity of the extract to lung epithelial cells was also investigated. It was found that POE has bacteriostatic effects at MIC 1&#8211;2 mg/mL, recognized as of limited efficacy, but at MIC/subMICs it targeted virulence not viability. It usually decreased <i>S. aureus</i> adhesion and less frequently inhibited biofilm formation on native and protein-conditioned surfaces. Observed effect seems to be related to significant reduction by POE of sortase A activity. However, in some cases POE favored the creation of biofilm by staphylococci and <i>S. aureus</i> adhesion to the lung epithelium was not limited. On the other side POE caused significant decrease of <i>S. a.</i> &#945;-toxin synthesis and slightly weakened the expression of SpA. When used at supraMICs POE eradicated mature biofilm, but in some cases with unsatisfying outcomes. Promisingly, POE has been recognized as a safe product, with no cytotoxicity up to 4 mg/mL. These results reflect the positive, negative or neutral anti-staphylococcal properties of POE. It seems that POE may be beneficial as a prophylactic, but not as a therapeutic or supportive agent in the area of CF&#8212;integrative medicine. However, introduction the official recommendations needs further in vivo studies.
topic lungwort fractionated phenolic extract
cystic fibrosis
<i>Staphylococcus aureus</i>
adhesion
biofilm
cytotoxicity
url https://www.mdpi.com/1420-3049/24/6/1151
work_keys_str_mv AT beatasadowska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT urszulawojcik theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT justynakrzyzanowskakowalczyk theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT mariuszkowalczyk theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT annastochmal theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT joannarywaniak theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT juliaburzynska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT barbararozalska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT beatasadowska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT urszulawojcik iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT justynakrzyzanowskakowalczyk iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT mariuszkowalczyk iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT annastochmal iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT joannarywaniak iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT juliaburzynska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
AT barbararozalska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates
_version_ 1725194823315488768